Plagiarism/Ethics Statement
Plagiarism and Publication Ethics Statement
The Journal of Clinical Diabetes and Obesity is committed to maintaining the highest standards of publication ethics, research integrity, and scientific excellence. The journal expects authors, reviewers, editors, and publishers to uphold ethical principles that promote honesty, transparency, accountability, and respect throughout the publication process.
Authors must submit manuscripts that are original, accurate, and prepared in accordance with accepted scientific and ethical standards. All sources of information, data, figures, and previously published material must be appropriately cited. Plagiarism in any form, including direct copying, improper paraphrasing, self-plagiarism, duplicate publication, fabricated or falsified data, manipulated images, and other forms of research misconduct, is unacceptable. Manuscripts suspected of violating these principles may be rejected during editorial review or, if published, may be corrected or retracted following an appropriate investigation.
Research involving human participants must be conducted in accordance with internationally recognized ethical principles and applicable institutional or national regulations. Where required, authors should obtain approval from an appropriate Institutional Review Board (IRB) or Ethics Committee before initiating the study and confirm that informed consent was obtained from all participants or their legally authorized representatives. Patient confidentiality and privacy must be protected at every stage of the research and publication process.
Studies involving animals must comply with institutional and national guidelines governing the ethical care and use of laboratory animals. Authors should describe the ethical approval obtained and the measures implemented to ensure animal welfare throughout the study.
The journal requires complete transparency regarding funding sources, potential conflicts of interest, and individual author contributions. Any financial, professional, or personal relationships that could influence the interpretation of research findings must be disclosed within the manuscript. Authors are also encouraged to make research data available when appropriate to support transparency, reproducibility, and scientific verification.
Editors are responsible for making impartial editorial decisions based on scientific merit, originality, methodological quality, and relevance to the journal's scope. Reviewers are expected to evaluate manuscripts objectively, maintain confidentiality, provide constructive feedback, and disclose any conflicts of interest that could affect their judgment.
If ethical concerns arise before or after publication, the journal will investigate them in a fair, timely, and confidential manner. When necessary, appropriate editorial actions, including corrections, expressions of concern, or article retractions, will be taken to preserve the integrity of the scientific record.
The Journal of Clinical Diabetes and Obesity is dedicated to fostering responsible scientific communication and supporting ethical research practices that contribute to advances in diabetes care, obesity management, metabolic health, and related clinical disciplines.